N. Matsumoto, M. Takahashi / Tetrahedron Letters 46(2005) 5551–5554
5553
Tomimatsu, Y.; Satoh, K.; Sakamoto, M. Heterocycles
1977, 8, 109–114; (h) Fuchigami, T.; Odo, K. Bull. Chem.
Soc. Jpn. 1977, 50, 1793–1796; (i) Gilchrist, T. L.; Moody,
C. L. Chem. Rev. 1977, 77, 409–435.
ride (778 mg, 2.0 mmol), and sodium hydride (60% in oil,
120 mg, 3.0 mmol) in dry THF (10 mL) was refluxed for
20 h. The resulting mixture was dissolved in water
(100 mL) and then extracted with CH2Cl2 (3 · 100 mL).
The combined organic layer was dried over MgSO4,
filtered, and concentrated under reduced pressure. The
crude materialwas purified by coulmn chromatography
on silica gel using AcOEt/CH2Cl2 (1/1) as eluent to give N-
(1,3-dimethyl-5-styryluracil-6-yl)-S,S-diphenylsulfilimine
(3c) (157 mg, 71%), as light-yellow needles, mp 154–155 ꢁC
(MeOH); IR (KBr) 1684, 1635, 1537, 1442, 1419 cmꢀ1; 1H
NMR (CDCl3) d 3.38 (s, 3H), 3.56 (s, 3H), 6.50 (d,
J = 16.0 Hz, 1H), 6.81–6.83 (m, 2H), 7.04–7.06 (m, 3H),
7.26 (d, J = 16.0 Hz, 1H), 7.46–7.55 (m, 6H), 7.69–7.72 (m,
4H); MS m/z (%) 255 (M+ꢀ186, 10), 186 (100), 92 (10), 77
(25); UV (MeOH) kmax (loge) 206 (4.7), 232 (4.5), 307
(4.3). Anal. Calcd for C26H23N3O2S: C, 70.72; H, 5.25; N,
9.52. Found: C, 70.43; H, 5.27; N, 9.53. Compound 3d:
64%, mp 171–172 ꢁC (MeOH); IR (KBr) 1683, 1633, 1612,
1545, 1444 cmꢀ1; 1H NMR (CDCl3) d 2.27 (s, 3H), 3.38 (s,
3H), 3.56 (s, 3H), 6.45 (d, J = 16.0 Hz, 1H), 6.73 (d,
J = 8.0 Hz, 2H), 6.88 (d, J = 8.0 Hz, 2H), 7.22 (d,
J = 16 Hz, 1H), 7.47–7.71 (m, 10H); MS m/z (%) 269
(M+ꢀ186, 17), 212 (15), 186 (100). Compound 3e: 88%,
mp 177–178 ꢁC (MeOH); IR (KBr) 1684, 1633, 1529,
1444 cmꢀ1; 1H NMR (CDCl3) d 3.38 (s, 3H), 3.55 (s, 3H),
6.45 (d, J = 16.0 Hz, 1H), 6.67–6.70 (m, 2H), 6.98–7.00 (m,
2H), 7.26 (d, J = 16.0 Hz, 1H), 7.48–7.73 (m, 10H); MS m/
z (%) 289 (M+ꢀ186, 26), 232 (22), 186 (100), 175 (21), 109
(19).
2. Matsumoto, N.; Takahashi, M. Tetrahedron 2002, 58,
10073–10079.
3. Matsumoto, N.; Takahashi, M. Heterocycles 2003, 60,
2677–2684.
4. (a) Bhuyan, P. J.; Lekhok, K. C.; Sandhu, J. S. J. Chem.
Res. (Synop.) 1998, 502–503; (b) Bhuyan, P. J.; Sandhu, J.
S.; Ghosh, A. C. Tetrahedron Lett. 1996, 37, 1853–1854;
(c) Itoh, T.; Tomii, Y.; Ogura, H.; Mizuno, Y. J.
Heterocycl. Chem. 1987, 24, 1215–1217; (d) Itoh, Y.;
Fujii, I.; Tomii, Y.; Nishimura, H.; Ogura, H.; Mizuno,
Y.; Kawahara, N.; Shimamori, T. Heterocycles 1986, 24,
927–930.
5. Tamura, Y.; Sakaguchi, T.; Kawasaki, T.; Kita, Y. Chem.
Pharm. Bull. 1976, 24, 1160–1164.
6. (a) Edstrom, E. D.; Wei, Y. J. Org. Chem. 1995, 60, 5069–
5076; (b) Edstrom, E. D.; Wei, Y. J. Org. Chem. 1994, 59,
6902–6903; (c) Edstrom, E. D.; Wei, Y. J. Org. Chem.
1993, 58, 403–407.
7. Bernier, J.-L.; HeÕnichart, J.-P. J. Heterocycl. Chem. 1979,
16, 717–720.
8. Seela, F.; Kretschmer, U. J. Heterocycl. Chem. 1990, 27,
479–486.
9. Yamasaki, T.; Nishida, K.; Okamoto, Y.; Okawara, T.;
Furukawa, M. Heterocycles 1998, 47, 315–327.
10. (a) Ishikawa, I.; Khachatrian, V. E.; Mizuno, Y.; Ogura,
H. Chem. Pharm. Bull. 1992, 40, 846–850; (b) Itoh, T.;
Ishikawa, I.; Ogura, H. Chem. Pharm. Bull. 1989, 37,
3184–3190.
11. Edstrom, E. D.; Yuan, W. Tetrahedron Lett. 1991, 32,
323–326.
12. Noguchi, M.; Fujimoto, N.; Nagashima, M.; Kajigaeshi,
S. Heterocycles 1989, 29, 1993–1996.
13. For recent reports, see: (a) Bio, M. M.; Xu, F.; Waters,
M.; Williams, J. M.; Savary, K. A.; Cowden, C. J.; Yang,
C.; Buck, E.; Song, Z. J. J. Org. Chem. 2004, 69, 6257–
6266; (b) Gangjee, A.; Vidwans, A.; Elzein, E.; Macguire,
J. J. J. Med. Chem. 2001, 44, 1993–2003; (c) Renau, T. E.;
Kennedy, C.; Ptak, R. G.; Breitenbach, J. M.; Drach, J.
C.; Townsend, L. B. J. Med. Chem. 1996, 39, 3470–3476;
(d) El-Bayouki, K. A. M.; Basyouni, W. M.; Hosni, H. J.
Chem. Res. (Synop.) 1995, 314–315.
17. A typicalexperimentalprocedure. Method A. A soul tion
of 3a (231 mg, 0.50 mmol) in acetonitrile (50 mL) was
irradiated for 10 min using a high-pressure mercury lamp
under a nitrogen atmosphere. The resulting solution was
concentrated under reduced pressure. After the residue had
been washed with diethyl ether, the resultant solid was
separated by filtration, and recrystallized from methanol to
give 6-trifluoroacetyl-1,3-dimethyl-1,2,3,4-tetrahydro-7H-
pyrrolo[2,3-d]pyrimidine-2,4-dione (6a) (124 mg, 90%) as
white powder, mp 292–293 ꢁC (lit.,21 mp 281 ꢁC); IR (KBr)
1
3188, 3113, 1730, 1678, 1645, 1606, 1570, 1421 cmꢀ1; H
NMR (CDCl3) d 3.22 (s, 3H), 3.50 (s, 3H), 7.51 (q,
J = 2.0 Hz, 1H); MS m/z (%) 275 (M+, 65), 218 (35), 206
(24), 149 (97), 66 (100). Anal. Calcd for C10H8F3N3O3: C,
43.65; H, 2.93; N, 15.27. Found: C, 43.59; H, 3.00; N,
15.34. Method B. A solution of 3a (231 mg, 0.50 mmol) in
ethanol(30 mL) was irradiated for 5.0 h using sunilght
under aerial atmosphere. The resulting solution was
concentrated under reduced pressure. After the residue
had been washed with diethyl ether, the resultant solid was
separated by filtration, and recrystallized from methanol to
give 6a (121 mg, 88%). Compound 6b: mp 214–215 ꢁC
(MeOH); IR (KBr) 3352, 1722, 1678, 1649, 1597, 1566,
1246, 1153 cmꢀ1; 1H NMR (CDCl3) d 1.50 (d, J = 6.8 Hz,
6H), 1.62 (d, J = 6.8 Hz, 6H), 4.90 (qq, J = 6.8 and 6.8 Hz,
1H), 5.26 (qq, J = 6.8 and 6.8 Hz, 1H), 7.72 (q, J = 2.0 Hz,
1H), 10.20 (br s, 1H); MS m/z (%) 331 (M+, 54), 247 (100),
231 (64), 294 (57), 174 (64), 161 (72), 135 (65). Compound
6c: mp 287–289 ꢁC (MeOH); IR (KBr) 3188, 1687, 1637,
1568 cmꢀ1; 1H NMR (CDCl3) d 3.23 (s, 3H), 3.54 (s, 3H),
6.84 (s, 1H), 7.23–7.77 (m, 5H), 11.58 (br s, 1H); MS m/z
(%) 255 (M+, 100), 198 (65), 183 (15), 170 (32), 155 (15), 104
(15). Compound 6d: mp 330–332 ꢁC (MeOH); IR (KBr)
14. Hojo, M.; Masuda, R.; Kokuryo, Y.; Shioda, H.; Matsuo,
S. Chem. Lett. 1976, 499–502.
15. A typicalexperimentalprocedure. A mixture of
1a2
(339 mg, 1.0 mmol) and 214 (504 mg, 3.0 mmol) in CH2Cl2
(3 mL) was stirred for 5 days at room temperature. The
resulting mixture was concentrated under reduced pres-
sure. The crude materialwas purified by coul mn chroma-
tography on silica gel using CH2Cl2 as eluent to give N-[5-
(4,4,4-trifluoro-3-oxo-1-butenyl)-1,3-dimethyluracil-6-yl]-
S,S-diphenylsulfilimine (3a) (346 mg, 75%), as light-yellow
needles, mp 207–208 ꢁC (MeOH); IR (KBr) 1695, 1641,
1
1537, 1495, 1439 cmꢀ1; H NMR (CDCl3) d 3.36 (s, 3H),
3.65 (s, 3H), 7.53–7.84 (m, 12H); MS m/z (%) 275
(M+ꢀ186, 16), 259 (16), 186 (100), 147 (24); UV (MeOH)
kmax (loge) 206 (4.7), 339 (4.1), 407 (4.3) nm. Anal. Calcd
for C22H18F3N3O3S: C, 57.26; H, 3.93; N, 9.11. Found: C,
57.29; H, 3.98; N, 9.13. Compound 3b: 77%, mp 152–
153 ꢁC (MeOH); IR (KBr) 1687, 1637, 1547, 1475, 1441,
1
1
1254 cmꢀ1; H NMR (CDCl3) d 1.45 (d, J = 6.8 Hz, 6H),
3273, 1698, 1684, 1641, 1568 cmꢀ1; H NMR (CDCl3) d
1.46 (d, J = 6.8 Hz, 6H), 5.20 (qq, J = 6.8 and 6.8 Hz, 1H),
5.63 (qq, J = 6.8 and 6.8 Hz, 1H), 7.26–7.78 (m, 12H); MS
m/z (%) 517 (M+, 6), 331 (8), 289 (13), 247 (14), 186 (100).
2.31 (s, 3H), 3.23 (s, 3H), 3.53 (s, 3H), 6.77 (s, 1H), 7.21 (d,
J = 8.0 Hz, 2H), 7.65 (d, J = 8.0 Hz, 2H), 11.53 (br s, 1H);
MS m/z (%) 269 (100), 212 (76), 185 (73), 169 (32).
Compound 6e: mp 340–342 ꢁC (MeOH); IR (KBr) 3300,
16. A typicalexperimentalprocedure. A mixture of
(183 mg, 0.50 mmol), benzyltriphenylphosphonium chlo-
42
1688, 1633, 1566 cmꢀ1 1H NMR (DMSO-d6) d 3.23 (s,
;